Volasertib, low dose, d1q3w
1230.15
Phase 1 small_molecule completed
Quick answer
Volasertib, low dose, d1q3w for Neoplasms is a Phase 1 program (small_molecule) at Boehringer Ingelheim with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Boehringer Ingelheim
- Indication
- Neoplasms
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed